Stonebridge Capital Advisors’s Avanos Medical AVNS Stock Holding History

Stonebridge Capital Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-437	Closed	-$8.84K	–	261
2023 Q3	$8.84K	Hold	437	–	–	﹤0.01%	624
2023 Q2	$11.2K	Hold	437	–	–	﹤0.01%	605
2023 Q1	$13K	Hold	437	–	–	﹤0.01%	573
2022 Q4	$11.8K	Hold	437	–	–	﹤0.01%	572
2022 Q3	$10K	Hold	437	–	–	﹤0.01%	572
2022 Q2	$12K	Sell	437 -9	-2%	-$259	﹤0.01%	567
2022 Q1	$15K	Sell	446 -50	-10%	-$1.61K	﹤0.01%	581
2021 Q4	$17K	Hold	496	–	–	﹤0.01%	531
2021 Q3	$15K	Sell	496 -474	-49%	-$16.1K	﹤0.01%	548
2021 Q2	$39K	Buy	970 +485	+100%	+$20.1K	﹤0.01%	511
2021 Q1	$21K	Buy	+485	New	+$22.8K	﹤0.01%	494
2020 Q3	–	Sell	-485	Closed	-$14K	–	222
2020 Q2	$14K	Hold	485	–	–	﹤0.01%	442
2020 Q1	$13K	Hold	485	–	–	﹤0.01%	447
2019 Q4	$16K	Hold	485	–	–	﹤0.01%	480
2019 Q3	$18K	Hold	485	–	–	﹤0.01%	466
2019 Q2	$21K	Buy	+485	New	+$20.7K	﹤0.01%	443

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonebridge Capital Advisors's AVNS Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 437 shares — an estimated $8.84K sold.

Stonebridge Capital Advisors first reported a position in AVNS in Q2 2019 and held it in 16 quarters. The position peaked at $39K in Q2 2021. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 437 Avanos Medical shares in Q4 2023, an estimated $8.84K.
Stonebridge Capital Advisors first reported a position in Avanos Medical in Q2 2019 and held it in 16 quarters.
Stonebridge Capital Advisors's Avanos Medical position peaked at $39K in Q2 2021.
265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.